Dear Colleagues, Dear Friends,
We warmly invite you to the 49th Brno Oncology Days and the 39th Nursing Conference, one of the leading multidisciplinary oncology meetings in the Czech Republic. This conference serves as a key platform for sharing knowledge, presenting research, and fostering collaboration among oncologists, nurses, and other healthcare professionals.
Building on the success of last year, when Brno Oncology Days (BOD) and the Nursing Conference (KNZP) welcomed 2,510 participants, we are excited to bring you another inspiring edition. This year’s conference will once again offer a rich program of expert-led lectures, workshops, cutting-edge research presentations, and poster sessions. Conference is covering the entire spectrum of oncology from diagnosis and treatment to palliative and supportive care, as well as survivorship and prevention. Alongside the Nursing Conference (KNZP), the program will also feature the Clinical Laboratory Conference, Clinical Research Sessions, General Practitioners’ Forum, and the Psycho-Oncology Conference.
We are also introducing an exciting new feature – ONCO Cinema, which will showcase a series of expert-commented videos with real case demonstrations of surgical procedures and oncology interventions.
Stay updated on conference preparations by following our website.
We look forward to seeing you in September!
Dates of BOD conference:
3-5 September 2025
9-11 September 2026

Networking Brings Professionals Together
Join us in Brno and network with your colleagues, interact with key opinion leaders, ask questions, and debate burning topics in the field of medical oncology in a uniquely meaningful way.
Brno Oncology Days
Brno Oncology Days (BOD) is known for convening oncology experts in a friendly setting for three days of inspiring, innovative discussion on the most relevant challenges in oncology and for multidisciplinary meetings, treatment standards/guidelines, educational and scientific sessions. The conference objectives are designed to introduce the audience to the standard of care but also the latest information on modern therapies and emerging treatments in early development.